Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-137544
Filing Date
2024-12-17
Accepted
2024-12-17 20:54:48
Documents
1
Period of Report
2024-12-13

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 9128
  Complete submission text file 0000950170-24-137544.txt   10738
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Issuer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1613 RAY DRIVE BURLINGAME CA 94010
Business Address
Wilson Mark Andrew (Reporting) CIK: 0001808356 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-24006 | Film No.: 241557433